title: Evaluation of an enzyme immunoassay for detection of Histoplasma capsulatum antigen from urine specimens.
abstract: Detection of Histoplasma capsulatum urinary antigen (UAg) is important for the initial diagnosis of infection and for monitoring of patient responses to antifungal therapy. This study evaluated an analyte-specific reagent (ASR) enzyme immunoassay (EIA) for the detection of H. capsulatum UAg from Immuno Mycologics, Inc. (IMMY) (Norman, OK) in comparison with routine testing with the MiraVista (MVista) H. capsulatum quantitative EIA (MiraVista Diagnostics, Indianapolis, IN). Using prospectively collected urine specimens (n = 1,003), we observed an overall percent agreement between the two assays of 97.6% (979/1,003 samples). Compared with the MVista EIA, the sensitivity and specificity of the IMMY ASR EIA were 64.5% (40/62 samples) and 99.8% (939/941 samples), respectively, using a cutoff value of 0.5 ng/ml. Based on available clinical histories for 23/24 discordant samples, 5 IMMY assay-negative/MVista assay-positive samples were considered falsely positive. Furthermore, 10/23 discordant samples were positive by the MVista EIA but were below the limit of quantitation (<0.4 ng/ml). The clinical significance of these low positive results in the MVista EIA is unclear. In addition to the prospective study, we tested 11 urine specimens collected from patients with culture-confirmed Histoplasma infections, and 100% (11/11 samples) were positive by the IMMY ASR EIA. In conclusion, the IMMY ASR EIA may offer an alternative approach for the detection of Histoplasma UAg. Additional prospective studies are needed to better characterize the performance of the IMMY ASR EIA in conjunction with clinical and laboratory findings.
authors: Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology.
authors: Elitza S
authors: ES
authors: Theel
authors: Deborah J
authors: DJ
authors: Jespersen
authors: Julie
authors: J
authors: Harring
authors: Jay
authors: J
authors: Mandrekar
authors: Matthew J
authors: MJ
authors: Binnicker
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000946:Antigens, Fungal / Q000652:urine*; D002648:Child; D019411:Clinical Laboratory Techniques / Q000379:methods*; D003955:Diagnostic Tests, Routine / Q000379:methods*; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D006658:Histoplasma / Q000737:chemistry*; D006660:Histoplasmosis / Q000175:diagnosis*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D055815:Young Adult
chemical_list: D000946:Antigens, Fungal
references: Clin Chest Med. 2009 Jun;30(2):217-25, v
references: 19375629
references: Ann Intern Med. 1982 Nov;97(5):680-5
references: 6814316
references: Radiology. 1983 Sep;148(3):839-43
references: 6878708
references: Clin Infect Dis. 2011 Sep;53(5):448-54
references: 21810734
references: Expert Opin Biol Ther. 2006 Nov;6(11):1207-21
references: 17049017
references: Clin Infect Dis. 2007 Oct 1;45(7):807-25
references: 17806045
references: Clin Chest Med. 2009 Jun;30(2):379-89, viii
references: 19375642
references: Clin Vaccine Immunol. 2007 Dec;14(12):1587-91
references: 17913863
references: Transpl Infect Dis. 2006 Sep;8(3):128-39
references: 16913971
references: Clin Vaccine Immunol. 2007 Jun;14(6):802-3
references: 17409220
references: Am J Med. 1992 Feb;92(2):153-60
references: 1543199
references: J Clin Microbiol. 2013 Nov;51(11):3555-9
references: 23966508
references: Clin Microbiol Rev. 2007 Jan;20(1):115-32
references: 17223625
references: Clin Vaccine Immunol. 2011 Apr;18(4):661-6
references: 21307278
references: Emerg Infect Dis. 2011 Sep;17(9):1664-9
references: 21888792
references: Clin Infect Dis. 1997 Jun;24(6):1169-71
references: 9195077
references: J Clin Microbiol. 2011 Sep;49(9):3204-8
references: 21752970
references: Trends Microbiol. 2003 Oct;11(10):488-94
references: 14557032